Mergers and Acquisitions

Emergent to Acquire Opioid-Focused Adapt Pharma in Deal Worth $735 Million

September 06, 2018

Emergent BioSolutions is set to acquire Adapt Pharma, a pharmaceutical company focused on addressing the opioid overdose and addiction crisis, in a deal worth up to $735 million.

Novartis to Sell Parts of Sandoz in $1-Billion Deal

September 06, 2018

Novartis will sell selected portions of its Sandoz United States portfolio to Aurobindo Pharma USA for $900 million in cash, plus $100 million in potential earn-outs.

Bayer Sells Prescription Dermatology Unit

September 04, 2018

Skin-focused company LEO Pharma acquired Bayer’s prescription treatment portfolio.

Sotera Health’s Nelson Labs Acquires Gibraltar Laboratories

August 29, 2018

Pharmaceutical Technology's In the Lab eNewsletter

The acquisition strengthens Nelson Labs’ outsourced testing capabilities for the pharmaceutical and medical device industries.

Novo Nordisk Acquires Ziylo in Potential $800-Million Deal

August 27, 2018

The acquisition will support Novo Nordisk’s development of glucose-responsive insulins.

Astellas Acquires Gene Therapy Company Quethera

August 17, 2018

The acquisition will strengthen Astellas Pharma’s position in ophthalmology.

Key Biologics and Astarte Biologics Merge

August 09, 2018

Pharmaceutical Technology's In the Lab eNewsletter

The combined companies will provide research- and clinical-grade human immune cells, blood products, and related services.

The acquisition will increase Metrohm’s spectroscopy offerings and capabilities.